Determination of diclofenac and its metabolites in human urine by GC-MS

GC-MS를 이용한 소변 중 Diclofenac 및 대사체 분석

  • Received : 2008.10.31
  • Accepted : 2008.12.04
  • Published : 2008.12.25

Abstract

This study has been described the metabolism and excretion in a healthy male urine collected for 26hrs after oral administration of diclofenac. To detect conjugated metabolites of diclofenac, urine sample was acid-hydrolyzed under the conditions of 6M-HCl at over $110^{\circ}C$ for 1hr. During the acidic hydrolysis process, diclofenac and its metabolites were converted into their corresponding lactam-ring through dehydration reaction. As results of chemical conversion by means of hydrolysis, the structures of diclofenac and its metabolites were also changed acidic to basic forms. However, lactam-ring was degraded by hydroxyl ion at basic condition. Thus, the extraction rate of dehydrated diclofenac and its metabolites was not favored at basic condition. For the determination of trace amounts of diclofenac and its metabolites in urine, trimethylsilylation (TMS) with MSTFA was applied and followed by analysis with gas chromatograph-mass spectrometer. In this study, four metabolites that are formed by the hydroxylation of parent drug were mainly detected. Each metabolite was tentatively identified by both interpretation of mass spectra and comparison with previously reported results. In addition, time profile of urinary excretion rate for parent drugs and metabolites was studied. Finally, the metabolic pathway of diclofenac was suggested on the basis of the elucidation of its metabolites and excretion profiles.

Keywords

diclofenac;urine;metabolites;TMS;GC/MS;mass spectrum

References

  1. T. Hirai, S. Matsumoto and I. Kishi, J. Chromatogr. B, 692, 375(1997) https://doi.org/10.1016/S0378-4347(96)00509-9
  2. P. Dorado, R. Berecz, M. C. Caceres and A. L. Lerena, J. Chromatogr. B, 789, 437(2003) https://doi.org/10.1016/S1570-0232(03)00137-5
  3. A. Sioufi, F. Pommier and J. Godbillon, J. Chromatogr., 571, 87(1991) https://doi.org/10.1016/0378-4347(91)80436-G
  4. W. W. Lee, S. H. Ahn, S. W. Lee and J. Hong, Anal. Sci. Technol., 20, 315(2007)
  5. R. E. Billings, Drug Metab. Dispos., 13, 287(1985)
  6. D. Stulten, M. Lamshoft, S. Zuhlke and M. Spiteller, J. Pharm. Biomed. Anal. 47, 371(2008) https://doi.org/10.1016/j.jpba.2008.01.024
  7. C. R. Creveling, N. Dalgard, H. Shimizu and J. W. Daly, Mol. Pharmacol., 6, 691(1970)
  8. G. Gonzalez, R. Ventura, A. K. Smith, R. Torre and J. Segura, J. Chromatogr. A, 719, 251(1996) https://doi.org/10.1016/0021-9673(95)00370-3
  9. T. Leemann, C. Transon and P. Dayer, Life Sci., 52, 29(1993) https://doi.org/10.1016/0024-3205(93)90285-B
  10. 의약화학, 의약화학 편집위원회, p. 85-106, 신일상사, 2004
  11. J. Frau, M. Coll, J. Donoso, F. Munoz, B. Vilanova and F. Garcia-Blanco, Electron. J. Theor. Chem., 2, 5665 (1997)
  12. X. S. Miao, B. G. Koenig and C. D. Metcalfe, J. Chromatogr. A, 952, 139(2002) https://doi.org/10.1016/S0021-9673(02)00088-2
  13. L. L. Brunton, J. S. Lazo and K. L. Parker, Goodman & Gilman's The Pharmacological Basis of Therapeutics, McGraw-Hill, 2006
  14. R. T. Morrison and R. N. Boyd, Organic Chemistry, Allyn and Bacon Inc, London, 1987
  15. B. Boudikova, C. Szumlanski, B. Maidak and R. Weinshilboum, Clin. Pharmacol. Ther., 48, 381(1990) https://doi.org/10.1038/clpt.1990.166
  16. A. Shafiee, M. Amini and M. Hajmahmodi, J. Sci. I. R. Iran, 14, 21(2003)
  17. B. M. El Haj, A. M. Al Ainri, M. H. Hassan, R. K. Bin Khadem and M. S. Marzouq, Foren. Sci. Inter., 105, 141(1999) https://doi.org/10.1016/S0379-0738(99)00106-1
  18. W. Blum, J. W. Faigle, U. Pfaar and A. Sallmann, J. Chromatogr. B, 685, 251(1996) https://doi.org/10.1016/S0378-4347(96)00198-3